Summary

Declares that any international agreement produced by the World Health Assembly/International Negotiating Body on pandemic prevention, preparedness, and response must be treated as a treaty and submitted to the Senate for advice and consent (two-thirds) before the United States can agree to or implement it. It expresses the Senate’s preference that the President not accept or implement such an agreement if it cannot win two‑thirds support in the Senate and records findings and concerns about the WHO and the INB negotiating process. The measure does not create funding or new programs; it sets a binding procedural rule for how the executive branch must treat and approve future WHO pandemic-related instruments negotiated under the INB, limiting executive flexibility by requiring Senate ratification for adoption or implementation by the U.S.

Key Points

• Any WHO/INB instrument on pandemic prevention, preparedness, and response is to be treated as a treaty requiring Senate advice and consent (two‑thirds).
• The President must seek Senate ratification before the U.S. may agree to or implement such WHO instruments.
• The Senate expresses a preference that the U.S. not join or implement such an instrument if two‑thirds support in the Senate cannot be obtained.
• The bill records findings and criticisms about WHO, INB negotiations, and guidance on treaty vs. executive agreement treatment.
• No new spending, programs, or operational authorities are created; the measure is procedural and constitutional in focus.
• The law constrains executive flexibility to accept international public-health instruments without Senate ratification.
• Could slow or block U.S. participation in WHO-negotiated pandemic agreements if two‑thirds Senate support is not achievable.
• Affects how federal agencies and negotiators approach future WHO INB negotiations and the legal status of any resulting instruments.

Categories & Tags